Clinical Trial Update: Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses [NA]

View source ↗

Summary

This clinical trial is evaluating a photoprotection product, Anthelios Fluide 100 KA+ UVMune 400, for prevention of actinic damage. The study, sponsored by Cosm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Anthelios Fluide 100 KA+ UVMune 400

Snippet

Sponsor: Cosmetique Active International | Conditions: Actinic Keratosis (AK) | NA | Status: RECRUITING